Products in development to treat head and neck cancer

Company Product Description Indication Phase
Cel-Sci (CVN) Multikine Combination of cytokines including IL-2 Head and neck cancer II
Celgene (CELG) Thalomid Small molecule alpha-(N-phthalimido) glutarimide immunomodulatory agent Recurrent squamous cell carcinoma of the head and neck II
Cobra Gene Directed Enzyme Prodrug Therapy (GDEPT) Gene therapy that directs conversion of prodrug into cytotoxic compound within tumors Head and neck cancer I/II